Coronary Microvascular Dysfunction Clinical Trial
Official title:
A Phase II Study Testing the Feasibility and Efficacy of Coronary Sinus Narrowing in Patients With Coronary Microvascular Dysfunction
This study is being done to evaluate the role of a novel implantable device, called The Neovasc Reducer™ System, in improving microvascular function, symptoms and quality of life in symptomatic patients with coronary microvascular dysfunction.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT06306066 -
Coronary Thermo-dilution Derived Flow-indices in Chronic Coronary Syndrome
|
||
| Recruiting |
NCT05288361 -
The DISCOVER INOCA Prospective Multi-center Registry
|
||
| Terminated |
NCT04614467 -
A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction
|
Phase 2 | |
| Recruiting |
NCT06089031 -
Belgian Registry on Coronary Function Testing
|
||
| Enrolling by invitation |
NCT06083155 -
The NetherLands Registry of Invasive Coronary Vasomotor Function Testing (NL-CFT)
|
||
| Completed |
NCT05009667 -
A Prospective, Multi-center Clinical Trial for Evaluating the Effectiveness and Safety of Online Coronary Angiography-Derived Index of Microcirculatory Resistance (caIMR)
|
||
| Active, not recruiting |
NCT05197361 -
Microvascular Coronary Resistance and Absolute Coronary FLOW in Patients With Percutaneous Intervention of a Chronic Total Occlusion
|
||
| Recruiting |
NCT05825339 -
Absolute Flow for Ischemia With No Obstructive Coronary Arteries
|
||
| Recruiting |
NCT05294887 -
Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease
|
Phase 4 | |
| Not yet recruiting |
NCT05790876 -
Super Saturated Oxygen (SSO2) Therapy in Patients With ST-segment Elevation Myocardial Infarction (STEMI) and Action on Coronary Microcirculation Dysfunction
|
N/A | |
| Completed |
NCT04959357 -
The Evaluation of Left Ventricular Systolic Function in Different Types of Ischemic Heart Disease
|
||
| Recruiting |
NCT05711719 -
Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction
|
Phase 2 | |
| Recruiting |
NCT06294730 -
COronary Microcirculation and Troponin Elevation in Septic Shock
|
||
| Recruiting |
NCT05841485 -
COVID-19 Microvascular Evaluation Trial
|
||
| Recruiting |
NCT03876223 -
Women's Ischemia Syndrome Evaluation (WISE) Pre-HFpEF
|
||
| Completed |
NCT05471739 -
Simultaneous Assessment of Coronary Microvascular Dysfunction and Ischemia With Non-obstructed Coronary Arteries With Intracoronary Electrocardiogram and Intracoronary Doppler
|
||
| Completed |
NCT02333591 -
Effect of Intact GLP-1 (7-36) and GLP-1 Metabolite (9-36) on Coronary and Peripheral Vascular Function in Adults
|
Phase 4 | |
| Completed |
NCT01014949 -
Microcirculation Assessment in Diabetes and Metabolic Syndrome
|
N/A | |
| Active, not recruiting |
NCT06008041 -
Multimodal Epicardial and Endocardial COronary PHYsiological Evaluation in Pathological Situations (PHYCO)
|
||
| Recruiting |
NCT05984537 -
A Study on the Impact of Bivalirudin Usage During PCI for High-risk Plaques on Post-PCI Coronary Microcirculation.
|
Phase 4 |